Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Viablife Biotech is a synthetic biology company specializing in the large-scale production of high-value natural products and active ingredients. The company utilizes a proprietary biomanufacturing platform that integrates metabolic engineering, microbial fermentation, and enzymatic synthesis. Its product portfolio includes high-purity antioxidants and anti-aging compounds such as hydroxytyrosol, ergothioneine, ectoine, and nicotinamide mononucleotide (NMN). Viablife serves a global market across the pharmaceutical, cosmetic, and nutraceutical industries, providing sustainable alternatives to traditional chemical synthesis. The company operates state-of-the-art manufacturing facilities that comply with international quality standards, including GMP. By focusing on green chemistry, Viablife aims to reduce the environmental impact of industrial chemical production while maintaining high product efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Viablife Biotech.